Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 40

1.

Induction of Peripheral Tolerance in Ongoing Autoimmune Inflammation Requires Interleukin 27 Signaling in Dendritic Cells.

Thomé R, Moore JN, Mari ER, Rasouli J, Hwang D, Yoshimura S, Ciric B, Zhang GX, Rostami AM.

Front Immunol. 2017 Oct 27;8:1392. doi: 10.3389/fimmu.2017.01392. eCollection 2017.

2.

IL-27-Induced Type 1 Regulatory T-Cells Produce Oxysterols that Constrain IL-10 Production.

Vigne S, Chalmin F, Duc D, Clottu AS, Apetoh L, Lobaccaro JA, Christen I, Zhang J, Pot C.

Front Immunol. 2017 Sep 25;8:1184. doi: 10.3389/fimmu.2017.01184. eCollection 2017.

3.

Interleukin-27 signalling induces stem cell antigen-1 expression in T lymphocytes in vivo.

Liu Z, Wu L, Zhu J, Zhu X, Zhu J, Liu JQ, Zhang J, Davis JP, Varikuti S, Satoskar AR, Zhou J, Li MS, Bai XF.

Immunology. 2017 Dec;152(4):638-647. doi: 10.1111/imm.12805. Epub 2017 Aug 23.

PMID:
28758191
4.

Immunomodulation of autoimmune arthritis by pro-inflammatory cytokines.

Kim EY, Moudgil KD.

Cytokine. 2017 Oct;98:87-96. doi: 10.1016/j.cyto.2017.04.012. Epub 2017 Apr 25. Review.

PMID:
28438552
5.

Serum osteopontin is a biomarker of severe fibrosis and portal hypertension in human and murine schistosomiasis mansoni.

Pereira TA, Syn WK, Pereira FE, Lambertucci JR, Secor WE, Diehl AM.

Int J Parasitol. 2016 Dec;46(13-14):829-832. doi: 10.1016/j.ijpara.2016.08.004. Epub 2016 Oct 10.

6.

Systemic delivery of IL-27 by an adeno-associated viral vector inhibits T cell-mediated colitis and induces multiple inhibitory pathways in T cells.

Zhu X, Liu Z, Liu JQ, Zhu J, Zhang J, Davis JP, Chu J, Yu J, Zhou J, Li MS, Bai XF.

J Leukoc Biol. 2016 Aug;100(2):403-11. doi: 10.1189/jlb.3A1215-540R. Epub 2016 Apr 22.

7.

Promotion of Expansion and Differentiation of Hematopoietic Stem Cells by Interleukin-27 into Myeloid Progenitors to Control Infection in Emergency Myelopoiesis.

Furusawa J, Mizoguchi I, Chiba Y, Hisada M, Kobayashi F, Yoshida H, Nakae S, Tsuchida A, Matsumoto T, Ema H, Mizuguchi J, Yoshimoto T.

PLoS Pathog. 2016 Mar 18;12(3):e1005507. doi: 10.1371/journal.ppat.1005507. eCollection 2016 Mar.

8.

NK-DC crosstalk controls the autopathogenic Th17 response through an innate IFN-γ-IL-27 axis.

Chong WP, van Panhuys N, Chen J, Silver PB, Jittayasothorn Y, Mattapallil MJ, Germain RN, Caspi RR.

J Exp Med. 2015 Sep 21;212(10):1739-52. doi: 10.1084/jem.20141678. Epub 2015 Sep 7.

9.

Osteopontin Potentiates Pulmonary Inflammation and Fibrosis by Modulating IL-17/IFN-γ-secreting T-cell Ratios in Bleomycin-treated Mice.

Oh K, Seo MW, Kim YW, Lee DS.

Immune Netw. 2015 Jun;15(3):142-9. doi: 10.4110/in.2015.15.3.142. Epub 2015 Jun 25.

10.

No quiet surrender: molecular guardians in multiple sclerosis brain.

Steinman L.

J Clin Invest. 2015 Apr;125(4):1371-8. doi: 10.1172/JCI74255. Epub 2015 Apr 1. Review.

11.

The Yin and Yang aspects of IL-27 in induction of cancer-specific T-cell responses and immunotherapy.

Li MS, Liu Z, Liu JQ, Zhu X, Liu Z, Bai XF.

Immunotherapy. 2015;7(2):191-200. doi: 10.2217/imt.14.95. Review.

12.

Mechanisms of NDV-3 vaccine efficacy in MRSA skin versus invasive infection.

Yeaman MR, Filler SG, Chaili S, Barr K, Wang H, Kupferwasser D, Hennessey JP Jr, Fu Y, Schmidt CS, Edwards JE Jr, Xiong YQ, Ibrahim AS.

Proc Natl Acad Sci U S A. 2014 Dec 23;111(51):E5555-63. doi: 10.1073/pnas.1415610111. Epub 2014 Dec 8.

13.
14.

Central muscarinic cholinergic activation alters interaction between splenic dendritic cell and CD4+CD25- T cells in experimental colitis.

Munyaka P, Rabbi MF, Pavlov VA, Tracey KJ, Khafipour E, Ghia JE.

PLoS One. 2014 Oct 8;9(10):e109272. doi: 10.1371/journal.pone.0109272. eCollection 2014.

15.

Cellular factors targeting APCs to modulate adaptive T cell immunity.

Visperas A, Do J, Min B.

J Immunol Res. 2014;2014:750374. doi: 10.1155/2014/750374. Epub 2014 Jul 14. Review.

16.

Timed action of IL-27 protects from immunopathology while preserving defense in influenza.

Liu FD, Kenngott EE, Schröter MF, Kühl A, Jennrich S, Watzlawick R, Hoffmann U, Wolff T, Norley S, Scheffold A, Stumhofer JS, Saris CJ, Schwab JM, Hunter CA, Debes GF, Hamann A.

PLoS Pathog. 2014 May 8;10(5):e1004110. doi: 10.1371/journal.ppat.1004110. eCollection 2014 May.

17.

Reverse interferon signature is characteristic of antigen-presenting cells in human and rat spondyloarthritis.

Fert I, Cagnard N, Glatigny S, Letourneur F, Jacques S, Smith JA, Colbert RA, Taurog JD, Chiocchia G, Araujo LM, Breban M.

Arthritis Rheumatol. 2014 Apr;66(4):841-51. doi: 10.1002/art.38318.

18.

Osteopontin expression by CD103- dendritic cells drives intestinal inflammation.

Kourepini E, Aggelakopoulou M, Alissafi T, Paschalidis N, Simoes DC, Panoutsakopoulou V.

Proc Natl Acad Sci U S A. 2014 Mar 4;111(9):E856-65. doi: 10.1073/pnas.1316447111. Epub 2014 Feb 18.

19.

Adrenomedullin protects from experimental autoimmune encephalomyelitis at multiple levels.

Pedreño M, Morell M, Robledo G, Souza-Moreira L, Forte-Lago I, Caro M, O'Valle F, Ganea D, Gonzalez-Rey E.

Brain Behav Immun. 2014 Mar;37:152-63. doi: 10.1016/j.bbi.2013.11.021. Epub 2013 Dec 7.

20.

The interdependent, overlapping, and differential roles of type I and II IFNs in the pathogenesis of experimental autoimmune encephalomyelitis.

Naves R, Singh SP, Cashman KS, Rowse AL, Axtell RC, Steinman L, Mountz JD, Steele C, De Sarno P, Raman C.

J Immunol. 2013 Sep 15;191(6):2967-77. doi: 10.4049/jimmunol.1300419. Epub 2013 Aug 19.

Supplemental Content

Support Center